Company / Inventory per Share
NeoGenomics Laboratories, Inc. Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.22
FY2025
5-year range
$0.19 / $0.22
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#106 of 114
Health Care
What the data says
Among 114 Health Care companies, NeoGenomics Laboratories, Inc. is in the bottom 7% for inventory per share. Inventory per Share has fluctuated over the past 10 years, ranging from $0.08 in FY2016 to $0.26 in FY2020.
Based on SEC 10-K filings.
0.22 in FY2025 with a 5-year CAGR of -3.3%.
Improved from $0.19 to $0.22 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- -3.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 114This company $0.22 Sector average $7.23
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, inventory per share increased 5.6% year-over-year.
- Ranks #106 out of 114 companies in the Health Care sector.
- Peak inventory per share was recorded in FY2020.
- Lowest inventory per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | +5.6% |
| FY2024 | $0.21 | +9.7% |
| FY2023 | $0.19 | -1.5% |
| FY2022 | $0.20 | +0.2% |
| FY2021 | $0.20 | -26.2% |
| FY2020 | $0.26 | +90.0% |
| FY2019 | $0.14 | +47.2% |
| FY2018 | $0.09 | -0.7% |
| FY2017 | $0.10 | +15.3% |
| FY2016 | $0.08 | -2.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026